• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Hip Pain

Article

Oral etidronate, IV pamidronate, and then zoledronate caused bone markers to normalize in this 80-year-old woman-temporarily. What’s going on? Answer this and questions on 3 other topics in this week’s quiz.

 

Question 1:

Answer and new question on next page »

The correct answer is d. Paget disease of bone.
For a discussion of the case, click here.

 

Question 2:

Answer and new question on next page »

The correct answer is a. True.
For a discussion of the case, click here.

 

Question 3:

Answer and new question on next page »

The correct answer is c. Exercise echocardiography.
For a discussion of the case, click here.

 

Question 4:

A 58-year-old man with a history of chronic sinus disease and hypothyroidism presented with left periorbital pain and erythema that worsened despite treatment with topical antibiotics. CT showed pansinusitis and orbital stranding. Orbital inflammatory syndrome was diagnosed.

Answer on next page »

The correct answer is a. True. For a discussion of the case, click here.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.